News and Announcements
Read the latest news from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. The links below take you to articles where you can learn more about our center's latest events and accomplishments. You can also visit the article archive for older news.
Northwestern Medicine scientists have discovered a new compound that halts the spread of multiple types of cancer cells.
June M. McKoy, MD, MPH, JD, MBA, associate professor of Medicine in the Division of General Internal Medicine and Geriatrics, has been named to the Executive Editorial Board for JNCCN-Journal of the National Comprehensive Cancer Network (NCCN). She currently represents the Lurie Cancer Center on the NCCN Guidelines Panel for Older Adult Oncology.
The words you don’t want to hear from a pharmaceutical company after presenting a new potential drug that obliterates cancer in mice: “It’s too early.” “Supporting research early in the pipeline is critical to bringing it to clinical trials,” said Leonidas Platanias, MD, PhD, Director of the Lurie Cancer Center
Scientists discovered the regulatory role of the enzyme CDK5 in an aggressive form of brain cancer and successfully halted tumor growth by inhibiting it.
On May 3, Lurie Cancer Center’s Basic Research Seminar hosted the Steven T. Rosen Lectureship, held to honor the scientific contributions of Lurie Cancer Center’s former director, Steven Rosen, MD.
The addition of a chemotherapy drug to adjuvant hormone therapy did not improve survival for patients with high-risk prostate cancer, according to a new study.
Alexis A. Thompson, MD, MPH, professor of Pediatrics in the Division of Hematology, Oncology and Stem Cell Transplantation, was the corresponding author of a paper published in the New England Journal of Medicine.
Study characterizes proteins resulting from RAS gene mutations, found in more than 20 percent of all human cancers
Last week, Lurie Cancer Center Director, Leonidas Platanias, MD, PhD, met with members of the Chicago Fire Department about plans to identify and reduce cancer risk for our firefighters.
New chair Daniel Brat, MD, PhD, is spearheading transformations in pathology, a field that’s rapidly evolving in parallel with advances in precision medicine and a trend toward sub-specialization.
Scientists found more than 100 possible cancer-causing mutations and defective alleles in a large-scale genetic analysis of pediatric cancers that was co-authored by Elizabeth Perlman, MD, and published in Nature.
Patients with advanced prostate cancer who received more intensive treatment experienced worse quality of life at three months, but better overall in the long-term, according to a new Northwestern Medicine study.
A drug called dasatinib was found to be safe and effective for children with chronic myeloid leukemia, according to a study published in the Journal of Clinical Oncology.
Among patients with stage III colon cancer, regular nut consumption was associated with significantly lower rates of cancer recurrence and death, according to a new study.
Leonidas Platanias, MD, PhD, has been named Chair of the Barbara Ann Karmanos Cancer Institute’s External Advisory Board.
William J. Gradishar, MD, has been appointed Chief of the Division of Hematology and Oncology at the Feinberg School of Medicine, effective April 1, 2018.
A new study has found that obese patients with metastatic melanoma live significantly longer than those with a normal body mass index — especially male patients treated with targeted or immune therapy.
Physicians and scientists in the Lurie Cancer Center's OncoSET program are teaming up to help pioneer precision oncology.
Deputy Director Maha Hussain, MD oversees clinical research at the Lurie Cancer Center, but never forgets her primary goal: having an impact on patients.
Neurosurgical-oncologist and his colleagues at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University are fighting back against long odds in a quest to develop novel ways to attack brain cancer.
See more news in the article archive.